Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
DiaMedica Therapeutics Inc. (DMAC)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
16 Nov 2023
Wambeke David J.
Chief Business Officer, Officer
DiaMedica Therapeutics Inc.
(DMAC)
527,114
+3%
20,000
$2.46
$49,200.00
BUY
23 Jun 2023
Pilnik Richard D.
Director
DiaMedica Therapeutics Inc.
(DMAC)
248,245
+18%
38,363
$3.91
$149,999.33
BUY
23 Jun 2023
Wambeke David J.
Chief Business Officer, Officer
DiaMedica Therapeutics Inc.
(DMAC)
507,114
+8%
38,364
$3.91
$150,003.25
BUY
23 Jun 2023
Kellen Scott
CFO and Secretary, Officer
DiaMedica Therapeutics Inc.
(DMAC)
32,290
+44%
10,000
$3.91
$39,100.00
BUY
23 Jun 2023
Semba Charles Pauling
Director
DiaMedica Therapeutics Inc.
(DMAC)
29,943
+74%
12,787
$3.91
$49,997.17
BUY
23 Jun 2023
Pauls Dietrich John
President and CEO, Director, Officer
DiaMedica Therapeutics Inc.
(DMAC)
68,591
+22%
12,787
$3.91
$49,997.17
BUY
23 Jun 2023
Giuffre Randall Michael
Director
DiaMedica Therapeutics Inc.
(DMAC)
360,355
+22%
65,000
$3.91
$254,150.00
BUY
23 Jun 2023
Von Koch Thomas
10% Owner
DiaMedica Therapeutics Inc.
(DMAC)
4,326,435
+51%
1,470,588
$3.40
$4,999,999.50
BUY
10 Apr 2023
Wambeke David J.
Chief Business Officer, Officer
DiaMedica Therapeutics Inc.
(DMAC)
468,750
+100%
468,750
$1.60
$750,000.00
BUY
8 Dec 2022
Giuffre Randall Michael
Director
DiaMedica Therapeutics Inc.
(DMAC)
260,225
+28%
57,079
$1.42
$81,022.97
BUY
6 Dec 2022
Giuffre Randall Michael
Director
DiaMedica Therapeutics Inc.
(DMAC)
203,146
+13%
24,874
$1.40
$34,708.60
BUY
5 Dec 2022
Pilnik Richard D.
Director
DiaMedica Therapeutics Inc.
(DMAC)
154,327
+29%
35,000
$1.39
$48,492.50
BUY
1 Dec 2022
Giuffre Randall Michael
Director
DiaMedica Therapeutics Inc.
(DMAC)
178,272
+0%
819
$1.19
$974.61
BUY
29 Nov 2022
Giuffre Randall Michael
Director
DiaMedica Therapeutics Inc.
(DMAC)
177,453
+60%
67,228
$1.20
$80,462.66
BUY
16 Nov 2022
Pauls Dietrich John
President and CEO, Director, Officer
DiaMedica Therapeutics Inc.
(DMAX)
55,804
+55%
20,000
$1.21
$24,200.00
BUY
8 Jul 2022
Von Koch Thomas
10% Owner
DiaMedica Therapeutics Inc.
(DMAC)
2,855,827
+7%
207,974
$1.33
$275,898.30
BUY
15 Sep 2021
ALCORN HARRY W JR
SVP, Clinical Operations, Officer
DiaMedica Therapeutics Inc.
(DMAC)
43,582
+52%
15,000
$3.80
$56,959.50
BUY
16 Aug 2021
Pilnik Richard D.
Director
DiaMedica Therapeutics Inc.
(DMAC)
83,065
+22%
15,000
$3.27
$49,064.00
BUY
16 Aug 2021
Burroughs Amy L.
Director
DiaMedica Therapeutics Inc.
(DMAC)
44,950
+100%
44,950
$3.15
$141,592.50
BUY
16 Aug 2021
ALCORN HARRY W JR
Senior VP, Clinical Operations, Officer
DiaMedica Therapeutics Inc.
(DMAC)
28,260
+274%
20,721
$3.09
$64,053.86
BUY
16 Aug 2021
Pauls Dietrich John
President and CEO, Director, Officer
DiaMedica Therapeutics Inc.
(DMAC)
35,804
+16%
5,000
$3.14
$15,700.00
BUY
16 Aug 2021
Kellen Scott
CFO and Secretary, Officer
DiaMedica Therapeutics Inc.
(DMAC)
22,290
+81%
10,000
$3.15
$31,463.00
BUY
4 Dec 2020
Pilnik Richard D.
Director
DiaMedica Therapeutics Inc.
(DMAC)
65,846
+17%
10,000
$5.37
$53,697.00
BUY
20 Nov 2020
Giuffre Randall Michael
Director
DiaMedica Therapeutics Inc.
(DMAC)
108,588
+16%
15,000
$4.26
$63,912.00
BUY
9 Nov 2020
Kellen Scott
CFO and Secretary, Officer
DiaMedica Therapeutics Inc.
(DMAC)
12,290
+19%
2,000
$4.19
$8,386.60
BUY
19 Aug 2019
Kellen Scott
CFO and Secretary, Officer
DiaMedica Therapeutics Inc.
(DMAC)
10,290
+41%
3,000
$2.43
$7,290.00
BUY
16 Aug 2019
Pilnik Richard D.
Director
DiaMedica Therapeutics Inc.
(DMAC)
50,678
+18%
7,840
$2.56
$20,039.04
BUY
16 Aug 2019
ALCORN HARRY W JR
Chief Medical Officer, Officer
DiaMedica Therapeutics Inc.
(DMAC)
8,260
+726%
7,260
$2.67
$19,365.32
BUY
16 Aug 2019
Pauls Dietrich John
President and CEO, Director, Officer
DiaMedica Therapeutics Inc.
(DMAC)
30,804
+3%
1,000
$2.68
$2,676.90
BUY
31 May 2019
Pilnik Richard D.
Director
DiaMedica Therapeutics Inc.
(DMAC)
42,838
+79%
19,000
$2.80
$53,200.00
BUY
24 May 2019
Kellen Scott
CFO and Secretary, Officer
DiaMedica Therapeutics Inc.
(DMAC)
7,290
+121%
4,000
$2.94
$11,770.00
BUY
27 Mar 2019
ALCORN HARRY W JR
Chief Medical Officer, Officer
DiaMedica Therapeutics Inc.
(DMAC)
1,150
+15%
150
$4.46
$668.39
BUY
11 Dec 2018
Pilnik Richard D.
Director
DiaMedica Therapeutics Inc.
(DMAC)
23,838
+35%
6,250
$4.00
$25,000.00
BUY
11 Dec 2018
Giuffre Randall Michael
Director
DiaMedica Therapeutics Inc.
(DMAC)
85,804
+15%
11,250
$4.00
$45,000.00
BUY
11 Dec 2018
Xiao Zhenyu
Director, 10% Owner
DiaMedica Therapeutics Inc.
(DMAC)
7,100
+84%
3,250
$4.00
$13,000.00
BUY
11 Dec 2018
Verdoorn Todd A.
Chief Scientific Officer, Officer
DiaMedica Therapeutics Inc.
(DMAC)
2,000
+100%
1,000
$4.00
$4,000.00
BUY
11 Dec 2018
Pauls Dietrich John
President and CEO, Director, Officer
DiaMedica Therapeutics Inc.
(DMAC)
29,804
+20%
5,000
$4.00
$20,000.00
BUY
11 Dec 2018
Parsons James T.
Director
DiaMedica Therapeutics Inc.
(DMAC)
6,100
+58%
2,250
$4.00
$9,000.00
BUY
11 Dec 2018
Kellen Scott
CFO and Secretary, Officer
DiaMedica Therapeutics Inc.
(DMAC)
3,290
+61%
1,250
$4.00
$5,000.00
BUY
11 Dec 2018
ALCORN HARRY W JR
Chief Medical Officer, Officer
DiaMedica Therapeutics Inc.
(DMAC)
1,000
+100%
1,000
$4.00
$4,000.00
Home